• Skip to primary navigation
  • Skip to main content

National Forum

  • Home
  • About
    • Advisory Leadership Council
    • Board of Directors
    • 2021-22 Strategic Plan
    • History
    • National Forum Awards
    • Team
    • Support
  • Collaborations
    • Counter Cholesterol™
    • Flu Prevention
    • Know Your Numbers
    • Million Hearts®
      • Million Hearts® Stakeholders Flu Vaccination Campaign ’22
    • Move with the Mayor™
    • Signature Reports
    • Stronger Hearts™
    • Value & Access
      • Value & Innovation Forum
  • Events
    • National Forum and Member Events
    • Health Equity Benefits Everyone – January 2023
    • 2022 Annual Meeting
    • 2022 Mid-Year Virtual Convening
    • 2021 Annual Meeting
    • 2021 Mid-Year Virtual Convening
    • Heart Failure Roundtable
    • Value & Innovation Forum
    • Meeting Archives
      • 2020 Annual Meeting
      • 2020 Mid-Year Meeting
      • 2019 Annual Meeting
      • 2019 Virtual Convening on Stroke
      • 2019 Mid-Year Member Meeting
      • 2018 Annual Meeting
      • 2018 Mid Year Meeting
  • Members
    • Membership
  • Newsroom
  • Search Toggle
  • Skip to content
Loading Events

« All Events

  • This event has passed.

Margolis Center for Health Policy | FDA – Medication Adherence: Landscape, Strategies, and Evaluation Methods

Tuesday, December 10, 2019 @ 9:00 am - 4:30 pm

  • « AHA’s West Virginia Stroke Conference
  • Missouri Hypertension Control Summit »

Description

Medication adherence—the extent to which patients take medications as prescribed in agreement with their health care provider—is an ongoing public health priority.[1][2]Although the prevalence of medication non-adherence varies by disease and condition, increased adherence can improve health and reduce economic burden.[3] Numerous strategies, including innovative tools and technologies, are used to assess and enhance medication, with variable success. This public meeting, convened under a cooperative agreement between the Robert J. Margolis, MD, Center for Health Policy at Duke University and the U.S. Food and Drug Administration, will explore the state of the science of clinical research evaluating medication adherence involving FDA-regulated products. Specific topics include:

  • Current landscape of interventions intended to (a) track (monitor) medication adherence, (b) improve medication adherence, and (c) improve clinical outcome(s) due to increased medication adherence;
  • Measurements of medication adherence; and
  • Study designs to evaluate the effectiveness of FDA-regulated products intended to track and/or improve medication adherence, with or without an association to clinical outcomes.

 

Funding for this meeting was made possible in part by a grant from the U.S. Food and Drug Administration. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the U.S. Food and Drug Administration nor does mention of trade names, commercial practices, or organizations imply endorsements.

December 10, 2019 – 9:00 am to 4:30 pm
Washington Marriott at Metro Center

775 12th Street NW

Washington, DC 20005

margolisevents@duke.edu
  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live

Details

Date:
Tuesday, December 10, 2019
Time:
9:00 am - 4:30 pm
Event Categories:
Partner Event, Value & Access
Website:
https://healthpolicy.duke.edu/events/medication-adherence-landscape-strategies-and-evaluation-methods#_ftn1
  • « AHA’s West Virginia Stroke Conference
  • Missouri Hypertension Control Summit »

1150 Connecticut Ave., NW, Suite 300, Washington, DC 20036 Phone: (866) 894-3500
Copyright © 2023 National Forum for Heart Disease & Stroke Prevention. All Rights Reserved
  • Facebook
  • Twitter
  • YouTube
Contact

"*" indicates required fields

Name * Required
This field is for validation purposes and should be left unchanged.